SOX2 and neoplasm: Furthermore, Sox2/Oct4 mediates the expression of interleukin 8 and 6, which, together with the signal peptide peptidase, mediate the shift of macrophage phenotype toward an immune-regulatory profile inhibiting immune response against tumor cells [66].